Palisade Bio Investor Relations Material
Latest events
Q1 2025
11 May, 2025
Q4 2024
24 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Palisade Bio Inc
Access all reports
Palisade Bio Inc is a U.S.-based clinical-stage biopharmaceutical company developing therapeutics for gastrointestinal health. The company focuses on reducing post-surgical complications and improving recovery outcomes through targeted enzyme inhibitors. It collaborates with research institutions and conducts clinical trials to advance its drug candidates. The company is headquartered in Carlsbad, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PALI
Country
🇺🇸 United States